Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02052115 : Behavioral Weight Loss and Exercise After Treatment (BEAT)
PhaseN/A
AgesMin: 21 Years Max: 69 Years
Eligibility
Inclusion Criteria:

- Breast cancer diagnosis

- Received surgery +/- chemotherapy +/- radiation for treatment of a Stage I, II or III
breast cancer. Ongoing treatment with monoclonal antibodies and/or anti-estrogen
therapy is acceptable

- Completion of initial therapy 6-36 months prior to study initiation

- BMI of 27-45 kg/m^2

Exclusion Criteria:

- Prior diagnosis of malignancy other than non-melanoma skin cancer (i.e. prior
non-melanoma skin cancer is not an exclusion criteria)

- Medical conditions that limit food choices such as celiac sprue or inflammatory bowel
disease

- Inability to walk on flat ground (or a treadmill) at 2.5 mph for 5 minutes

- Age <21 and >70

- Presence of body metal

- Psychotic or central nervous system impairment that would limit compliance with study
requirements, including dementia

- Evidence of metastatic disease

- Symptomatic heart disease (chest pain or equivalent with activity)

- Exercise limiting pulmonary disease or need for oxygen to exercise

- Individuals taking mood stabilizing medications including: Lithium, valproic acid,
also called divalproex sodium (Depakote), carbamazepine (Tegretol), lamotrigine
(Lamictal), oxcarbazepine (Trileptal), olanzapine (Zyprexa), aripiprazole (Abilify),
risperidone (Risperdal), ziprasidone (Geodon), clozapine (clorazil)

- Participants with an active neurologic disorder that affects the central nervous
system, including seizures, and Parkinson's disease

- Weight loss of >10 lbs in the previous 6 months

- Participation in > 150 minutes of moderate intensity activity by self report, unless
activity level by accelerometer is less than 150 minutes of moderate intensity
activity
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02052115      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740